Stebler
Camille Stebler, Fehren CH
Patent application number | Description | Published |
---|---|---|
20090152460 | System for Processing an Object - A processing system comprises a gas supply apparatus with which process gas is supplied to an object. An activation beam activates the gas thereby inducing a chemical reaction between material at the surface of the object and the process gas causing ablation of material from the surface or deposition of material at the surface. The gas supply apparatus is formed from a stack of plates providing a gas conduit system between at least one gas inlet and at least one gas outlet. | 06-18-2009 |
20100024730 | Processing system - A processing system for processing an object ( | 02-04-2010 |
20110292385 | Producing images of a specimen - Producing images of a specimen includes introducing a specimen into a specimen chamber of a particle-beam device, selecting a specific position on the surface of the specimen, supplying a contrast-agent precursor on the specific position, providing a particle beam and/or a light beam, guiding the particle beam and/or the light beam onto the specific position, applying a contrast-agent layer to the specific position as a result of the interaction of the particle beam and/or the light beam with the contrast-agent precursor, leaving the contrast-agent layer on the surface of the specimen for a predetermined amount of time. During the predetermined amount of time, a first part of the contrast-agent layer diffuses into the specimen and a second part of the contrast-agent layer remains on the surface of the specimen. The specimen is imaged using an optical device and/or a particle-optical device and/or using the particle beam. | 12-01-2011 |
20130098292 | Processing System - A processing system for processing an object ( | 04-25-2013 |
Kathrina Stebler, Uster CH
Patent application number | Description | Published |
---|---|---|
20100191089 | METHOD AND SYSTEM TO DETECT NEOINTIMA COVERAGE OF A STENT - A method and endovascular system, such as a balloon catheter, for detecting the absence of neointimal coverage of bare or drug-eluting metal stents, featuring two (bipolar systems) or more electrodes (multipolar systems). The distal part of the device has an expandable platform, such as an inflatable balloon, for providing transient mechanical contact of the electrodes to the stented vessel segment. The electrodes on the expandable platform have a circumferential-symmetric array, i.e., arrangement in identical circular sectors. For example, the electrodes are arranged in semicircles, i.e., at 90 and 180 degrees, when using a bipolar catheter system, or they are arranged in quarter-sections, i.e., at 90, 180, 270, and 360 degrees, when using a quadrupolar catheter system. The electrodes of the endovascular device connect with a direct current (DC) or alternating current (AC) measurement unit. With multipolar systems, rotational impedance measurement technology is used for accurate detection of exposed (non-covered) stent struts and is defined herein as sequential (clock-wise or counterclock-wise) testing of each single electrode against the remaining electrically interconnected electrodes. The described endovascular system requires direct mechanical contact of at least 2 electrically non-interconnected electrodes with the stent to induce short-circuit current. The method and system can distinguish complete neointimal stent coverage, defined as consistently high impedance values in all measurements, from partial neointimal coverage, defined as a mix of high and low impedance values, from missing neointimal coverage, defined as consistently low impedance values in all measurements. | 07-29-2010 |
Walter Stebler, Liestal CH
Patent application number | Description | Published |
---|---|---|
20080213385 | Formulations for 7- (T-Butoxy) Iminomethyl Camptothecin - The present invention relates to nanoparticulate compositions in which the active agent is a topoisomerase I inhibitor and pharmaceutical compositions comprising the nanoparticulate compositions that are useful for the treatment and prevention of proliferative diseases including cancer. | 09-04-2008 |